A team from the Salk Institute in La Jolla led by Inder Verma has reported dedifferentiation in a paper in Science some important findings that I believe make their paper in the top 10 as a candidate for paper of the year. The paper, entitled “Dedifferentiation of Neurons and Astrocytes by Oncogenes Can Induce Gliomas […]
Dedifferentiation of neurons & astrocytes into glioma forming cells Read More »
The FDA warning letter that Celltex received in late September (but that just went public yesterday–see my initial reaction here) is a possible game-changer for that company in my opinion. Why? The letter outlined in great detail the FDA’s concerns with how Celltex manufactures its stem cell product ranging from lack of documentation to concerns about aseptic/sterile
Will stem cell clinic Celltex reinvent itself after game-changing FDA warning letter? Read More »
Sugarland, Texas stem cell clinic, Celltex, is most well known for having done the stem cell treatment on Texas Governor Rick Perry. What’s up with Celltex this week? There has a lot of talk behind the scenes that something big has happened. Very recently Celltex put out a PR recently saying it had received a
I’m getting some heat from some stem cell folks who think I should not have blogged about the Moriguchi iPS cell transplant case. Their argument seems to be it would have been preferable to either (A) not blog about the story at all or only minimally so fewer people would know about it or (B)
Responding to critics of blogging the Moriguchi iPS cell story Read More »
How could the biggest newspaper in Japan, Yomiuri, get so badly tricked without even trying to verify facts prior to splashing it across their front page? A commenter on this blog named Mulboyne says that competing newspaper Mainichi was offered the Moriguchi story but solid investigative reporting made them decline it. Here’s the quote: “The
How did Japan’s top newspaper get tricked about iPS cells by Moriguchi? Read More »
Japan’s biggest daily newspaper, Yomiuri Shimbun, made international news when it reported a few days ago that iPS cells had been transplanted into human patients by Hisashi Moriguchi. In this morning’s paper, Yomiuri Shimbun issued a painful front page admission (happily reported by competing paper The Asahi Shimbun) of publishing false information about the alleged transplants, which
It seems like just yesterday I was blogging about how concerned I was that iPS cells might be used in early phase human clinical trials as early as next year and that would be high risk given safety concerns about iPS cells. Oh, it was yesterday. Now today….. Yomiuri Shimbun, one of the top newspapers
As I was compiling a list of the upcoming stem cell meetings the other day I got to thinking about the different kinds of stem cell meetings and how diverse they are. Some didactic in a stodgy kind of way, while others are just as educational and instructive, but in a more enjoyable format. Some
Why you should go to the World Stem Cell Summit Read More »
I’m a fan of iPS cells, but my lab has been concerned about the similarities between induced pluripotency and cancer formation for many years. We just now published a paper that directly addressed the similarities of cancer and iPS cell transcriptomes. These are cause for concern and need to be faced as we contemplate clinical
iPS cells are similar to cancer cells paper, part 2: unsettled reviewers Read More »
Top stem cell meetings and conferences. If you want me to post your meeting, email me or post a comment (I’ll delete the comment and add the meeting to the main page). Meetings from 2012 can be found here. My listing of these meetings is not an endorsement of them, but is provided for informational
Stem Cell Meetings & Conferences 2013 Read More »